Management of anastrozole-induced bone loss in breast cancer patients with oral risedronate: results from the ARBI prospective clinical trial

INTRODUCTION: The aim of this multicenter, phase III, prospective open label clinical trial was to investigate the effect of risedronate (R) on bone mineral density (BMD) in postmenopausal, early breast cancer (BC) patients scheduled to receive anastrozole (A). METHODS: Pre-treatment BMD of 213 pati...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Markopoulos, Christos, Tzoracoleftherakis, Evagelos, Polychronis, Athanassios, Venizelos, Basileios, Dafni, Urania, Xepapadakis, Grigorios, Papadiamantis, John, Zobolas, Vasilios, Misitzis, John, Kalogerakos, Kyriakos, Sarantopoulou, Angeliki, Siasos, Nikolaos, Koukouras, Dimitrios, Antonopoulou, Zoh, Lazarou, Spyros, Gogas, Helen
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2010
Assuntos:
Research article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2879572/
https://ncbi.nlm.nih.gov/pubmed/20398352
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/bcr2565
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados